Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder for which numerous mouse models have been generated. In both AD patients and mouse models, there is increasing evidence that neuronal dysfunction occurs before the accumulation of β-amyloid (Aβ)-containing plaques and neurodegeneration. Characterization of the timing and nature of preplaque dysfunction is important for understanding the progression of this disease and to identify pathways and molecular targets for therapeutic intervention. Hence, we have examined the progression of dysfunction at the morphological, functional, and behavioral levels in the Tg2576 mouse model of AD. Our data show that decreased dendritic spine density, impaired long-term potentiation (LTP), and behavioral deficits occurred months before plaque deposition, which was first detectable at 18 months of age. We detected a decrease in spine density in the outer molecular layer of the dentate gyrus (DG) beginning as early as 4 months of age. Furthermore, by 5 months, there was a decline in LTP in the DG after perforant path stimulation and impairment in contextual fear conditioning. Moreover, an increase in the Aβ42/Aβ40 ratio was first observed at these early ages. However, total amyloid levels did not significantly increase until ≈18 months of age, at which time significant increases in reactive astrocytes and microglia could be observed. Overall, these data show that the perforant path input from the entorhinal cortex to the DG is compromised both structurally and functionally, and this pathology is manifested in memory defects long before significant plaque deposition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The widely used Tg2576 mouse model expresses mutant human APP and displays decreased spine density in the CA1 and dentate gyrus, well before the development of amyloid plaques, further evidence that soluble Aβ oligomers initiate at least some Alzheimer’s disease–related pathology68,95.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [95]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Whereas high-frequency stimulation significantly increased the magnitude of long-term potentiation (LTP) at Schaffer collateral (SC)-CA1 synapses in the hippocampus of wild type (WT) mice, LTP was significantly impaired in 6-to 7-mo-old APP/PS1 mice (17,18).”
From IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline (2016) · cites this paper as [17]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This is different from the progression in Tg2576, which manifests synaptic damage at an early stage of pathological development (4.5 months) [68,69] with a corresponding decrease in synaptic density markers [70] prior to Aβ plaque development (10 months) [71] and cognitive deficiencies (one year) [72,73].”
From Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice (2019) · cites this paper as [69]
The cited source says what the claim attributes to it.
In the citing paper
“Tg2576 mice began to show impaired LTP and synaptic transmission in dentate gyrus (DG) at 4–5 mo or older (Jacobsen et al., 2006).”
From VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology (2011) · cites this paper as Jacobsen et al., 2006
In the citing paper
“The widely used Tg2576 mouse model expresses mutant human APP and displays decreased spine density in the CA1 and dentate gyrus, well before the development of amyloid plaques, further evidence that soluble Aβ oligomers initiate at least some Alzheimer’s disease–related pathology68,95.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [95]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2005) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,687
Life and Death of Neurons in the Aging Brain
Morrison, J. H., & Hof, P. R. (1997) · Science · doi:10.1126/science.278.5337.412 · Cited by 1,344
Self-citationDeciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
Cited by
Items 301–400 of 789
Balietti, M., Giorgetti, B., Casoli, T., Solazzi, M., Tamagnini, F., Burattini, C., Aicardi, G., & Fattoretti, P. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-121711 · Cited by 46
Use of Yokukansan (TJ‐54) in the treatment of neurological disorders: a review
de Caires, S., & Steenkamp, V. (2010) · Phytotherapy Research · doi:10.1002/ptr.3146 · Cited by 51
Benedetti, E., D'Angelo, B., Cristiano, L., Di Giacomo, E., Fanelli, F., Moreno, S., Cecconi, F., Fidoamore, A., Antonosante, A., Falcone, R., et al. (2014) · Cell Cycle · doi:10.4161/cc.28295 · Cited by 45
Down‐regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease
Rodriguez‐Perdigon, M., Tordera, R. M., Gil‐Bea, F. J., Gerenu, G., Ramirez, M. J., & Solas, M. (2016) · Hippocampus · doi:10.1002/hipo.22607 · Cited by 47
An Update on the Amyloid Hypothesis
Eckman, C. B., & Eckman, E. A. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.03.007 · Cited by 51
Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes
Knight, E. M., Kim, S. H., Kottwitz, J. C., Hatami, A., Albay, R., Suzuki, A., Lublin, A., Alberini, C. M., Klein, W. L., Szabo, P., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000237 · Cited by 47
Van Kampen, J. M., & Kay, D. G. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182896 · Cited by 47
Lee, K.-F., Tung, S., Teng, C., Shen, C., Hsieh, M. C., Huang, C.-Y., Lee, K., Lee, L., Chen, W.-P., Chen, C., et al. (2020) · Antioxidants · doi:10.3390/antiox9020137 · Cited by 50
Barbera, L. L., Nobili, A., Cauzzi, E., Paoletti, I., Federici, M., Saba, L., Giacomet, C., Marino, R., Krashia, P., Melone, M., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00580-6 · Cited by 50
Basi, G. S., Feinberg, H., Oshidari, F., Anderson, J., Barbour, R., Baker, J., Comery, T. A., Diep, L., Gill, D., Johnson-Wood, K., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.045187 · Cited by 41
Self-citationAnimal models of Alzheimer’s disease: Current strategies and new directions
Qing, W., Zhu, B. T., Bai-Ting, Z., & Peng, L. (2024) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2024.274 · Cited by 49
Porcellotti, S., Fanelli, F., Fracassi, A., Sepe, S., Cecconi, F., Bernardi, C., Cimini, A., Cerù, M. P., & Moreno, S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/967203 · Cited by 49
Synaptic contact number and size in stratum radiatum CA1 of APP/PS1ΔE9 transgenic mice
West, M. J., Bach, G., Søderman, A., & Jensen, J. L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.009 · Cited by 48
Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity
Severini, C., Lattanzi, R., Maftei, D., Marconi, V., Ciotti, M. T., Passeri, P. P., Florenzano, F., DUCA, E. D., Caioli, S., Zona, C., et al. (2015) · Scientific Reports · doi:10.1038/srep15301 · Cited by 49
Tozzi, A., Sclip, A., Tantucci, M., de Iure, A., Ghiglieri, V., Costa, C., Filippo, M. D., Borsello, T., & Calabresi, P. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.002 · Cited by 48
Enhanced degradation of synaptophysin by the proteasome in mucopolysaccharidosis type IIIB
Vitry, S., Ausseil, J., Hocquemiller, M., Bigou, S., Coura, R., & Heard, J. M. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.01.001 · Cited by 48
Role of grape seed polyphenols in Alzheimer’s disease neuropathology
Pasinetti, G. M., & Ho, L. (2010) · Nutrition and Dietary Supplements · doi:10.2147/nds.s6898 · Cited by 48
Bazrgar, M., Khodabakhsh, P., Prudencio, M., Mohagheghi, F., & Ahmadiani, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105805 · Cited by 47
Steele, J., Brautigam, H., Short, J. A., Sowa, A., Shi, M., Yadav, A., Weaver, C. M., Westaway, D. A., Fraser, P. E., George‐Hyslop, P. S., et al. (2014) · The Journal of Comparative Neurology · doi:10.1002/cne.23536 · Cited by 47
Lilja, A. M., Röjdner, J., Mustafiz, T., Thomé, C. M., Storelli, E., Gonzalez, D., Unger-Lithner, C., Greig, N. H., Nordberg, A., & Marutle, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058752 · Cited by 43
Aytan, N., Choi, J., Carreras, I., Crabtree, L., Nguyen, B., Lehar, M., Blusztajn, J. K., Jenkins, B. G., & Dedeoglu, A. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.02.045 · Cited by 46
Zheng, J., Xu, D., Li, K., Wang, H., Shen, P.-C., Lin, M., Cao, X.-H., & Wang, R. (2011) · PubMed · Cited by 46
Behavioral Defects in Chaperone-Deficient Alzheimer's Disease Model Mice
Ojha, J., Veeranan‐Karmegam, R., Masilamoni, J. G., Terry, A. V., & Cashikar, A. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016550 · Cited by 46
Höppener, J. W. M., Jacobs, H. M., Wierup, N., Sotthewes, G., Sprong, M., de Vos, P., Berger, R., Sundler, F., & Åhrén, B. (2008) · Journal of Diabetes Research · doi:10.1155/2008/697035 · Cited by 46
Townsend, M., Qu, Y., Gray, A. J., Wu, Z., Seto, T., Hutton, M., Shearman, M. S., & Middleton, R. E. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163691 · Cited by 44
Madrasi, K. J., Das, R., Abdul, H. M., Lin, L., Hyman, B. T., Lauffenburger, D. A., Albers, M. W., Rissman, R. A., Burke, J. M., Apgar, J. F., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12312 · Cited by 44
The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease
Krashia, P., Spoleti, E., & D’Amelio, M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1039725 · Cited by 45
Animal models of Alzheimer’s disease: preclinical insights and challenges
Xu, Q., Yang, W., Zhong, M., Lin, Z., Gray, N. E., & Xian, Y. (2023) · Acta Materia Medica · doi:10.15212/amm-2023-0001 · Cited by 45
Pardon, M.-C., Sarmad, S., Rattray, I., Bates, T. E., Scullion, G. A., Marsden, C. A., Barrett, D. A., Lowe, J., & Kendall, D. A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.002 · Cited by 39
Developmental neurotoxicity of PFOA exposure on hiPSC-derived cortical neurons
Wu, S., Xie, J., Zhao, H., Zhao, X., Sánchez, O. F., Rochet, J., Freeman, J. L., & Yuan, C. (2024) · Environment International · doi:10.1016/j.envint.2024.108914 · Cited by 44
Corsetti, V., Borreca, A., Latina, V., Giacovazzo, G., Pignataro, A., Krashia, P., Natale, F., Cocco, S., Rinaudo, M., Malerba, F., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa039 · Cited by 42
Saydoff, J. A., Olariu, A., Sheng, J., Hu, Z., Li, Q., Garcia, R., Pei, J., Sun, G. Y., & von Borstel, R. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-130059 · Cited by 34
Staging anti-inflammatory therapy in Alzheimer’s disease
Lichtenstein, M. P. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00142 · Cited by 39
Huang, J.-K., Ma, P.-L., Ji, S.-Y., Zhao, X.-L., Tan, J.-X., Sun, X.-J., & Huang, F.-D. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.11.006 · Cited by 38
Scherzer‐Attali, R., Farfara, D., Cooper, I., Levin, A., Benromano, T., Trudler, D., Vientrov, M., Shaltiel‐Karyo, R., Shalev, D. E., Segev‐Amzaleg, N., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.005 · Cited by 44
Rustay, N. R., Cronin, E. A., Curzon, P., Markosyan, S., Bitner, R. S., Ellis, T. A., Waring, J. F., Decker, M. W., Rueter, L. E., & Browman, K. E. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.040 · Cited by 43
Bhattacharya, S., Maelicke, A., & Montag, D. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142421 · Cited by 39
Lesuis, S. L., Kaplick, P. M., Lucassen, P. J., & Krugers, H. J. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.02.023 · Cited by 41
Probing neural circuit mechanisms in Alzheimer’s disease using novel technologies
Grieco, S. F., Holmes, T. C., & Xu, X. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02018-x · Cited by 42
Daumas, S., Sandin, J., Chen, K. S., Kobayashi, D., Tulloch, J., Martin, S. J., Games, D., & Morris, R. G. M. (2008) · Learning & Memory · doi:10.1101/lm.990208 · Cited by 40
Host and Viral Factors Influencing the Pathogenesis of HIV-Associated Neurocognitive Disorders
Jayadev, S., & Garden, G. A. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9154-6 · Cited by 42
Expression of Ambra1 in mouse brain during physiological and Alzheimer type aging
Sepe, S., Nardacci, R., Fanelli, F., Rosso, P., Bernardi, C., Cecconi, F., Mastroberardino, P. G., Piacentini, M., & Moreno, S. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.07.001 · Cited by 41
Microglia and modifiable life factors: Potential contributions to cognitive resilience in aging
Duggan, M. R., & Parikh, V. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113207 · Cited by 41
Mood and male sexual behaviour in the APP23 model of Alzheimer's disease
Vloeberghs, E., Dam, D. V., Franck, F., Staufenbiel, M., & DEDEYN, P. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.03.002 · Cited by 41
Advances on the Understanding of the Origins of Synaptic Pathology in AD
Lacor, P. (2007) · Current Genomics · doi:10.2174/138920207783769530 · Cited by 38
Significant structural but not physiological changes in cortical neurons of 12-month-old Tg2576 mice
Rocher, A. B., Kinson, M. S., & Luebke, J. I. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.07.014 · Cited by 41
Early temporal short-term memory deficits in double transgenic APP/PS1 mice
Lassalle-Lagadec, S., Rotureau, L., Hémar, A., Macrez, N., Delcasso, S., Jeantet, Y., & Cho, Y. H. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.07.023 · Cited by 41
Sen, A., Nelson, T. J., Alkon, D. L., & Hongpaisan, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171008 · Cited by 41
Perversi, F., Costa, C., Labate, A., Lattanzi, S., Liguori, C., Maschio, M. C. E., Meletti, S., Nobili, L., Operto, F. F., Romigi, A., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1182304 · Cited by 40
Neuritin can normalize neural deficits of Alzheimer’s disease
An, K., Jung, J. H., Jeong, A. Y., Kim, H. G., Jung, S., Lee, K., Kim, H. J., Kim, S.-J., Jeong, T.-Y., Son, Y., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.478 · Cited by 40
Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study
Holland, N., Malpetti, M., Rittman, T., Mak, E. E., Passamonti, L., Kaalund, S. S., Hezemans, F. H., Jones, P. S., Savulich, G., Hong, Y. T., et al. (2022) · Brain · doi:10.1093/brain/awab282 · Cited by 39
“It is closely related to cognitive decline in symptomatic stages of disease,(4,5) but can begin long before symptom onset and neuronal loss.(6) Synaptic loss and dysfunction may be an important mediator of decline even where atrophy is minimal or absent.”
Sanati, M., Aminyavari, S., Khodagholi, F., Hajipour, M. J., Sadeghi, P., Noruzi, M., Moshtagh, A., Behmadi, H., & Sharifzadeh, M. S. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.05.013 · Cited by 39
Remodeling of synapses in the CA1 area of the hippocampus after transient global ischemia
Ruan, Y., Han, X., Shi, Z., Lei, Z., & Xu, Z. C. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.035 · Cited by 39
Hanna, A., Iremonger, K., Das, P., Dickson, D., Golde, T., & Janus, C. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt124 · Cited by 38
Tabassum, S., Misrani, A., Tang, B., Chen, J., Yang, L., & Long, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-41114-3 · Cited by 38
Avenanthramide-C Restores Impaired Plasticity and Cognition in Alzheimer’s Disease Model Mice
Ramasamy, V. S., Samidurai, M., Park, H. J., Wang, M., Park, R. Y., Yu, S. Y., Kang, H. K., Hong, S., Choi, W., Lee, Y., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01707-5 · Cited by 38
Nucleotide excision repair in chronic neurodegenerative diseases
Sepe, S., Payán‐Gómez, C., Milanese, C., Hoeijmakers, J. H. J., & Mastroberardino, P. G. (2013) · DNA repair · doi:10.1016/j.dnarep.2013.04.009 · Cited by 39
Natural Amyloid-Beta Oligomers Acutely Impair the Formation of a Contextual Fear Memory in Mice
Kittelberger, K. A., Piazza, F., Tesco, G., & Reijmers, L. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029940 · Cited by 32
Deng, M., Zhang, Q., Wu, Z., Ma, T., He, A., Zhang, T., Ke, X., Yu, Q., Han, Y., & Lu, Y. (2020) · Aging Cell · doi:10.1111/acel.13144 · Cited by 37
Infliximab ameliorates AD-associated object recognition memory impairment
Kim, D. H., Choi, S., Jho, J., Park, M., Kang, J., Park, S. J., Ryu, J. H., Jo, J., Kim, H. H., & Kim, B. C. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.06.001 · Cited by 37
Pathway-Specific Alteration of Synaptic Plasticity in Tg2576 Mice
Jung, J. H., An, K., Kwon, O. B., Kim, H.-S., & Kim, J.-H. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0077-8 · Cited by 33
Nguyen, P. T., Kimura, T., Ho, S. A., Tran, A. H., Ono, T., & Nishijo, H. (2007) · Hippocampus · doi:10.1002/hipo.20281 · Cited by 37
A synapsin Ⅰ cleavage fragment contributes to synaptic dysfunction in Alzheimer's disease
Meng, L., Zou, L. B., Xiong, M., Chen, J., Zhang, X., Yu, T., Li, Y., Liu, C., Chen, G., Wang, Z., et al. (2022) · Aging Cell · doi:10.1111/acel.13619 · Cited by 36
Of mice and men: more neurobiology in dementia
Codita, A., Winblad, B. G., & Mohammed, A. H. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000245757.06374.6a · Cited by 37
Thakker, D. R., Sankaranarayanan, S., Weatherspoon, M. R., Harrison, J., Pierdomenico, M., Heisel, J. M., Thompson, L. A., Haskell, R., Grace, J. E., Taylor, S. J., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2262-14.2015 · Cited by 33
A novel ARC gene polymorphism is associated with reduced risk of Alzheimer’s disease
Landgren, S., von Otter, M., Palmér, M. S., Zetterström, C. E., Nilsson, S., Skoog, I. G., Gustafson, D., Minthon, L., Wallin, A., Andreasen, N., et al. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0823-x · Cited by 36
Kuwabara, Y., Ishizeki, M., Watamura, N., Toba, J., Yoshii, A., Inoue, T., & Ohshima, T. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12728 · Cited by 37
X11 rescues memory and long-term potentiation deficits in Alzheimer's disease APPswe Tg2576 mice
Mitchell, J. C., Ariff, B. B., Yates, D. M., Lau, K., Perkinton, M. S., Rogelj, B., Stephenson, J. D., Miller, C. C. J., & McLoughlin, D. M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp408 · Cited by 36
Ben-Nejma, I. R. H., Keliris, A., Daans, J., Ponsaerts, P., Verhoye, M., der Linden, A. V., & Keliris, G. A. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0810-7 · Cited by 36
Tournissac, M., Vu, T.-M., Vrabic, N., Hozer, C., Tremblay, C., Mélançon, K., Planel, E., Pifferi, F., & Calon, F. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00842-3 · Cited by 35
Enríquez-Barreto, L., Cuesto, G., Domıńguez-Iturza, N., Gavilán, E., Ruano, D., Sandi, C., Fernández‐Ruiz, A., Martín-Vázquez, G., Herreras, Ó., & Morales, M. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00054 · Cited by 35
Poirier, G. L., Amin, E., Good, M. A., & Aggleton, J. P. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.11.025 · Cited by 36
Roh, Y. H., Sim, S. J., Cho, I., Choi, N., & Bong, K. W. (2016) · The Analyst · doi:10.1039/c6an00188b · Cited by 35
Beckelman, B. C., Day, S. M., Zhou, X., Donohue, M., Gouras, G. K., Klann, E., Keene, C. D., & Ma, T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160036 · Cited by 35
Drebrin in Alzheimer’s Disease
Ishizuka, Y., & Hanamura, K. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-4-431-56550-5_12 · Cited by 35
Palmer, A., & Good, M. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390902 · Cited by 34
Caspase-12 Activation is Involved in Amyloid-β Protein-Induced Synaptic Toxicity
Quiroz‐Baez, R., Ferrera, P., Rosendo‐Gutiérrez, R., Morán, J., Bermúdez‐Rattoni, F., & Arias, C. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110326 · Cited by 34
Kim, K.-R., Kim, Y., Jeong, H., Kang, J.-S., Lee, S. H., Kim, Y., Lee, S., & Ho, W. (2021) · Molecular Brain · doi:10.1186/s13041-021-00774-x · Cited by 34
Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease
Gaamouch, F. E., Liu, K., Lin, H., Wu, C., & Wang, J. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105046 · Cited by 34
Self-citationChanges in the physiology of CA1 hippocampal pyramidal neurons in preplaque CRND8 mice
Wykes, R. C., Kalmbach, A., Eliava, M., & Waters, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.001 · Cited by 34
Nanostructured Antagonist of Extrasynaptic NMDA Receptors
Savchenko, A., Braun, G. B., & Molokanova, E. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b01988 · Cited by 34
Galoyan, A. A., Sarkissian, J. S., Chavushyan, V. A., Meliksetyan, I. B., Avagyan, Z. E., Poghosyan, М. V., Vahradyan, H. G., Mkrtchian, H., & Abrahamyan, D. O. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.10.019 · Cited by 34
Jiang, X., Chen, L.-L., Lan, Z., Xiong, F., Xu, X., Yin, Y.-Y., Li, P., & Wang, P. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02889-z · Cited by 33
Xu, A., Tang, Y., Zeng, Q., Wang, X., Tian, H., Zhou, Y., & Li, Z. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200242 · Cited by 33
Centaurin-α1-Ras-Elk-1 Signaling at Mitochondria Mediates β-Amyloid-Induced Synaptic Dysfunction
Szatmari, E. M., Oliveira, A. F., Sumner, E. J., & Yasuda, R. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2641-12.2013 · Cited by 33
Caenorhabditis elegans as a model organism to study APP function
Ewald, C. Y., & Li, C. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2905-7 · Cited by 34
Maingret, V., Barthet, G., Deforges, S., Jiang, N., Mulle, C., & Amédée, T. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.10.012 · Cited by 33
Inhibition of LTP in vivo by beta-amyloid peptide in different conformational states
Schmid, A. W., Freir, D. B., & Herron, C. E. (2007) · Brain Research · doi:10.1016/j.brainres.2007.11.056 · Cited by 33
Castro, M. A. D., & Volterra, A. (2021) · Glia · doi:10.1002/glia.24128 · Cited by 32
Prevention of microgliosis halts early memory loss in a mouse model of Alzheimer’s disease
Kater, M. S. J., Huffels, C. F. M., Oshima, T., Renckens, N. S., Middeldorp, J., Boddeke, E., Smit, A. B., Eggen, B. J. L., Hol, E. M., & Verheijen, M. H. G. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.10.009 · Cited by 32
Palavicini, J. P., Wang, H., Bianchi, E., Xu, S., Rao, J. S., Kang, D. E., & Lakshmana, M. K. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.183 · Cited by 32
Striatal-Enriched Protein Tyrosine Phosphatase in Alzheimer’s Disease
Xu, J., Kurup, P. K., Nairn, A. C., & Lombroso, P. J. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00009-x · Cited by 32
Hartl, D., Rohe, M., Mao, L., Staufenbiel, M., Zabel, C., & Klose, J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002759 · Cited by 32
Frydman‐Marom, A., Rechter, M., Shefler, I., Bram, Y., Shalev, D. E., & Gazit, E. (2008) · Angewandte Chemie · doi:10.1002/ange.200802123 · Cited by 32
Spoleti, E., Krashia, P., Barbera, L. L., Nobili, A., Lupaşcu, C. A., Giacalone, E., Keller, F., Migliore, M., Renzi, M., & D’Amelio, M. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113969 · Cited by 31
Murphy, M., Wilson, Y. M., Vargas, E., Munro, K. M., Smith, B., Huang, A., Li, Q., Xiao, J., Masters, C. L., Reid, C. A., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.014 · Cited by 31
Höfling, C., Morawski, M., Zeitschel, U., Zanier, E. R., Moschke, K., Serdaroglu, A., Canneva, F., Hörsten, S., De Simoni, M., Forloni, G., et al. (2016) · Aging Cell · doi:10.1111/acel.12508 · Cited by 24
Haseeb, M., Javaid, N., Yasmeen, F., Jeong, U., Han, J. H., Yoon, J., Seo, J. Y., Heo, J.-K., Shin, H. C., Kim, M. S., et al. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00831 · Cited by 31
Nasrouei, S., Rattel, J. A., Liedlgruber, M., Marksteiner, J., & Wilhelm, F. H. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.11.003 · Cited by 30
Sekiguchi, K., Imamura, S., Yamaguchi, T., Tabuchi, M., Kanno, H., Terawaki, K., Kase, Y., & Ikarashi, Y. (2010) · Phytotherapy Research · doi:10.1002/ptr.3287 · Cited by 30
Metadata
- Authors
- Jacobsen, J. S., Wu, C.-C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., Martone, R., Morrison, J. H., Pangalos, M. N., Reinhart, P. H., & Bloom, F. E.
- Affiliations
- Wyeth (US)
- Neurome, Inc., La Jolla, CA 92037; and
- Icahn School of Medicine at Mount Sinai (US)
- Scripps Research Institute (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-03-20
- Volume
- 103
- Issue
- 13
- Pages
- 5161-5166
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1405622
- OpenAlex
- W2136901555
- Cited by
- 701
- References
- 44
- Citations by year
- 2026: 17 · 2025: 16 · 2024: 26 · 2023: 31 · 2022: 24 · 2021: 32 · 2020: 26 · 2019: 32 · 2018: 35 · 2017: 28 · 2016: 42 · 2015: 26 · 2014: 40 · 2013: 35 · 2012: 46
- FWCI
- 30.71
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, dendritic spine density, long-term potentiation, dentate gyrus, perforant path, contextual fear conditioning, memory impairment, amyloid-beta 42/40 ratio, amyloid plaques, reactive astrocytes, microglia, entorhinal cortex
- MeSH terms
- Aging, Alzheimer Disease, Animals, Behavior, Animal, Brain, Disease Models, Animal, Fear, Memory, Mice, Transgenic, Organ Size, Spine, Synapses, Time Factors, Amyloid beta-Peptides, Synaptophysin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.